Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Yes, a single gene variant can cause symptoms in autosomal dominant conditions, because only one copy of the altered gene, inherited from either parent, is enough to trigger the disorder. Each child of an affected parent has a 50% chance of inheriting the variant, though how strongly symptoms appear can vary widely due to penetrance and expressivity. Some people carry the variant with mild or no obvious signs, while others develop significant health issues, and certain conditions like Huntington's disease or Marfan syndrome follow this pattern. Genetic testing and family history review help clarify risk, but interpretation depends on many individual factors. There are several important details to consider, so see below to understand more.
If you are noticing symptoms you cannot explain or have concerns about an inherited condition in your family, a free, instant, online symptom check can help you organize what you are experiencing and point you toward the right next steps, including which specialist to see or which questions to raise with your doctor.
Last reviewed for medical accuracy: 08/18/2026
Hypophosphatasia is a rare bone-mineral disorder caused by changes in the ALPL gene, which provides instructions for making an enzyme called alkaline phosphatase. In some families, a single altered copy of this gene (inherited from one parent) is enough to cause signs and symptoms. This pattern is known as autosomal dominant inheritance.
Below, we’ll explain how autosomal dominant transmission works, why one gene variant can lead to hypophosphatasia symptoms, and what you can do if you suspect you or a family member might be affected.
Autosomal dominant inheritance means:
Key points:
Hypophosphatasia (HPP) can follow autosomal dominant or autosomal recessive patterns. When inherited in an autosomal dominant way:
Yes. Here’s why a single variant in ALPL can lead to clinical signs:
Haploinsufficiency
Dominant Negative Effect
Tissue-Specific Impact
Age and Modifier Genes
Two important concepts explain why family members with the same ALPL variant can look very different:
This variability can make it challenging to predict who will become seriously affected.
If one parent has an autosomal dominant ALPL variant:
If you suspect hypophosphatasia in your family, consider:
Benefits of genetic counseling:
While there is no cure for hypophosphatasia, early recognition and supportive care can improve quality of life. Management may include:
If you’re experiencing unexplained tooth loss, bone pain, fractures, or other related issues, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Although hypophosphatasia symptoms can vary, certain signs warrant prompt medical attention:
Always speak to a doctor about anything that could be life-threatening or serious. A healthcare professional can guide you through appropriate testing, referrals, and management plans.
Understanding how hypophosphatasia inheritance from one parent works empowers you to make informed decisions about testing, monitoring, and care. Early recognition and a targeted management plan can help you or your loved ones maintain bone and dental health over a lifetime.
(References)
* Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frascá G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, De Marchi M. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int. 2002 Jun;61(6):1947-56. doi: 10.1046/j.1523-1755.2002.00379.x. PMID: 12028435.
* Fauvert D, Brun-Heath I, Lia-Baldini AS, Bellazi L, Taillandier A, Serre JL, de Mazancourt P, Mornet E. Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet. 2009 Jun 6;10:51. doi: 10.1186/1471-2350-10-51. Epub 2009 Jun 6. PMID: 19500388; PMCID: PMC2702372.
* Lohmann D. Retinoblastoma. Adv Exp Med Biol. 2010;685:220-7. doi: 10.1007/978-1-4419-6448-9_21. PMID: 20687510.
* Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM, Gregg A, Noggle S, Tessier-Lavigne M. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature. 2016 May 5;533(7601):125-9. doi: 10.1038/nature17664. Epub 2016 Apr 27. PMID: 27120160.
* Auer-Grumbach M, Toegel S, Schabhüttl M, Weinmann D, Chiari C, Bennett DLH, Beetz C, Klein D, Andersen PM, Böhme I, Fink-Puches R, Gonzalez M, Harms MB, Motley W, Reilly MM, Renner W, Rudnik-Schöneborn S, Schlotter-Weigel B, Themistocleous AC, Weishaupt JH, Ludolph AC, Wieland T, Tao F, Abreu L, Windhager R, Zitzelsberger M, Strom TM, Walther T, Scherer SS, Züchner S, Martini R, Senderek J. Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies. Am J Hum Genet. 2016 Sep 1;99(3):607-623. doi: 10.1016/j.ajhg.2016.07.008. PMID: 27588448; PMCID: PMC5011077.
* Pagnamenta AT, Kaisaki PJ, Bennett F, Burkitt-Wright E, Martin HC, Ferla MP, Taylor JM, Gompertz L, Lahiri N, Tatton-Brown K, Newbury-Ecob R, Henderson A, Joss S, Weber A, Carmichael J, Turnpenny PD, McKee S, Forzano F, Ashraf T, Bradbury K, Shears D, Kini U, de Burca A, DDD Study, Blair E, Taylor JC, Stewart H. Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome. Clin Genet. 2019 Jun;95(6):693-703. doi: 10.1111/cge.13533. Epub 2019 Apr 3. PMID: 30859559; PMCID: PMC6563422.
* Boucher S, Tai FWJ, Delmaghani S, Lelli A, Singh-Estivalet A, Dupont T, Niasme-Grare M, Michel V, Wolff N, Bahloul A, Bouyacoub Y, Bouccara D, Fraysse B, Deguine O, Collet L, Thai-Van H, Ionescu E, Kemeny JL, Giraudet F, Lavieille JP, Devèze A, Roudevitch-Pujol AL, Vincent C, Renard C, Franco-Vidal V, Thibult-Apt C, Darrouzet V, Bizaguet E, Coez A, Aschard H, Michalski N, Lefevre GM, Aubois A, Avan P, Bonnet C, Petit C. Ultrarare heterozygous pathogenic variants of genes causing dominant forms of early-onset deafness underlie severe presbycusis. Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31278-31289. doi: 10.1073/pnas.2010782117. Epub 2020 Nov 23. PMID: 33229591; PMCID: PMC7733833.
* Cousin MA, Creighton BA, Breau KA, Spillmann RC, Torti E, Dontu S, Tripathi S, Ajit D, Edwards RJ, Afriyie S, Bay JC, Harper KM, Beltran AA, Munoz LJ, Falcon Rodriguez L, Stankewich MC, Person RE, Si Y, Normand EA, Blevins A, May AS, Bier L, Aggarwal V, Mancini GMS, van Slegtenhorst MA, Cremer K, Becker J, Engels H, Aretz S, MacKenzie JJ, Brilstra E, van Gassen KLI, van Jaarsveld RH, Oegema R, Parsons GM, Mark P, Helbig I, McKeown SE, Stratton R, Cogne B, Isidor B, Cacheiro P, Smedley D, Firth HV, Bierhals T, Kloth K, Weiss D, Fairley C, Shieh JT, Kritzer A, Jayakar P, Kurtz-Nelson E, Bernier RA, Wang T, Eichler EE, van de Laar IMBH, McConkie-Rosell A, McDonald MT, Kemppainen J, Lanpher BC, Schultz-Rogers LE, Gunderson LB, Pichurin PN, Yoon G, Zech M, Jech R, Winkelmann J, Undiagnosed Diseases Network, Genomics England Research Consortium, Beltran AS, Zimmermann MT, Temple B, Moy SS, Klee EW, Tan QK, Lorenzo DN. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome. Nat Genet. 2021 Jul;53(7):1006-1021. doi: 10.1038/s41588-021-00886-z. Epub 2021 Jul 1. PMID: 34211179; PMCID: PMC8273149.
* Idiiatullina E, Al-Azab M, Lin M, Hrovat-Schaale K, Liu Z, Li X, Guo C, Chen X, Li Y, Gao S, Cui J, Zhou W, Liu L, Zhang Y, Masters SL. Heterozygous de novo dominant negative mutation of REXO2 results in interferonopathy. Nat Commun. 2024 Aug 6;15(1):6685. doi: 10.1038/s41467-024-50878-w. Epub 2024 Aug 6. PMID: 39107301; PMCID: PMC11303720.
* Wouters M, Ehlers L, Van Eynde W, Kars ME, Delafontaine S, Kienapfel V, Dzhus M, Schrijvers R, De Haes P, Struyf S, Bucciol G, Itan Y, Bolze A, Voet A, Hombrouck A, Moens L, Ogunjimi B, Meyts I. Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriers. J Exp Med. 2025 Nov 3;222(11). doi: 10.1084/jem.20250499. Epub 2025 Aug 27. PMID: 40864493; PMCID: PMC12382605.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.